We use cookies, including third-party cookies from Google to serve personalized ads through AdSense, to operate this site and understand how it is used. By continuing to browse, you accept this use. See our Privacy Policy and Terms of Use for details, including how to opt out of personalized advertising.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Mayo Clinic, Duke Conducting Study Comparing FUS With Uterine Artery Embolization
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Devices > Mayo Clinic, Duke Conducting Study Comparing FUS With Uterine Artery Embolization
Medical DevicesTechnology

Mayo Clinic, Duke Conducting Study Comparing FUS With Uterine Artery Embolization

EllenMcKenna
EllenMcKenna
Share
3 Min Read
SHARE

Patient enrollment is underway for the first US-based study comparing MR-guided focused ultrasound and uterine artery embolization (UAE) for the treatment of uterine fibroids. The study, called The Fibroid Interventions: Reducing Symptoms Today and Tomorrow (FIRSTT) trial, is now open at the Mayo Clinic in Rochester, MN and at Duke University in Durham, NC. Study participants will be randomly assigned for treatment with either FUS or UAE.

Patient enrollment is underway for the first US-based study comparing MR-guided focused ultrasound and uterine artery embolization (UAE) for the treatment of uterine fibroids. The study, called The Fibroid Interventions: Reducing Symptoms Today and Tomorrow (FIRSTT) trial, is now open at the Mayo Clinic in Rochester, MN and at Duke University in Durham, NC. Study participants will be randomly assigned for treatment with either FUS or UAE.

Expected to provide important insights regarding the benefits and potential drawbacks of newer non-surgical treatment approaches for uterine fibroids, the study will follow patients for three years. Its goal is to assess how effective treatments are in symptom relief, side effects, impact on women’s quality of life, need for additional treatment, potential for future fertility and even the costs associated with each approach.

“Many women suffering from fibroids go to their local doctor and are offered hysterectomy to treat their fibroids, but are given no long-lasting alternatives to surgery,” says Elizabeth A. Stewart, MD, Professor of Obstetrics and Gynecology at the Mayo Clinic. “Both UAE and FUS are excellent less invasive options for women, but we have very little scientific evidence comparing these two approaches. The major goal of this important study is to generate information that will guide physicians and patients on the options that are right for them.”

More Read

genetic therapy for leukemia
Is Genetic Therapy the Future for Treating Leukemia and Other Blood Disorders?
Why 2014 Should Be a Good Year for Consumer and Enterprise Health IT
The Five-Year Medical Degree
Majority of Seniors Want Digital Tools to Manage Their Health
Stem Cells-Part II – Rebuilding the Damaged Heart and Other Organs

The success of the FIRSTT trial depends on women participating in the research. The study seeks to enroll 220 women who can be treated at The Mayo Clinic in Rochester, Minnesota or Duke University in Durham, North Carolina. Complete information about the study and its eligibility requirements can be found here.

A Facebook group for women interested in the study has been established. Follow this link if you are interested.

TAGGED:clinical studyFUSUAE
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

Flat editorial illustration: The article's core relationship is that substantial clinical testing of thymosin alpha-1 did not est
Thymosin Alpha-1 Got the Big Trials Most Peptides Never Get
Global Healthcare
October 12, 2026
Flat editorial illustration: The article examines how researchers study tissue repair through growth factors and peptide-based re
How Researchers Study Tissue Repair: From Growth Factors to Peptide-Based Research
Health
October 12, 2026
Workers Comp Claim Denied – Now What?  -- AI-generated illustration
Workers Comp Claim Denied – Now What? 
Policy & Law
October 9, 2026
The Case for Proactive Nutrient Support and Where IV Therapy Fits In -- AI-generated illustration
The Case for Proactive Nutrient Support and Where IV Therapy Fits In
Health Therapies
October 5, 2026

You Might also Like

VESAG Mobile Diagnostics Watch
Medical Devices

VESAG Mobile Diagnostics Watch

December 22, 2011
eHealthMedical RecordsTechnology

7 Steps to Selecting the Right HIPAA Approved Cloud Fax Service

July 13, 2017
cloud services
BusinessPolicy & LawTechnology

Evaluating and Choosing Healthcare Cloud Service Providers

April 3, 2015

Technology Brings Virtual Care to Life

October 22, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2026 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?